The anti-cancer effects of CD71 antibodies can be achieved by direct cytotoxic effect through crosslinking of the receptor, or by antibody-dependent cell-mediated cytotoxicity/phagocytosis (ADCC/ADCP) based on Fc effector functions. This evidence concerns the gene TFRC and cancer.